03:36 PM EST - Tekmira Pharmaceuticals Corporation : announced that the United States Patent & Trademark Office has recently issued two key patents: one covering its lipid nanoparticle manufacturing process and the other covering the chemical modification of siRNA to mitigate immune stimulation. Tekmira Pharmaceuticals Corporation
shares T.TKM are trading down $0.01 at $2.89.
